Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis

Pain remains one of the most difficult-to-treat domains in patients with rheumatoid arthritis (RA). In clinical trials, the Janus kinase inhibitors (JAKis) have demonstrated good efficacy in pain relief. Aim of our study was to evaluate the real-life effectiveness of JAKis in improving pain in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: De Stefano, Ludovico, Bozzalla Cassione, Emanuele, Bottazzi, Francesca, Marazzi, Elena, Maggiore, Francesco, Morandi, Valentina, Montecucco, Carlomaurizio, Bugatti, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504158/
https://www.ncbi.nlm.nih.gov/pubmed/37500945
http://dx.doi.org/10.1007/s11739-023-03350-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504158/
https://www.ncbi.nlm.nih.gov/pubmed/37500945
http://dx.doi.org/10.1007/s11739-023-03350-4

Ejemplares similares